EP2134314A1 - Compositions résistantes au rayonnement ultraviolet, biodégradables, cytoprotectrices, transparentes ou translucides, à spf élevé - Google Patents

Compositions résistantes au rayonnement ultraviolet, biodégradables, cytoprotectrices, transparentes ou translucides, à spf élevé

Info

Publication number
EP2134314A1
EP2134314A1 EP08726964A EP08726964A EP2134314A1 EP 2134314 A1 EP2134314 A1 EP 2134314A1 EP 08726964 A EP08726964 A EP 08726964A EP 08726964 A EP08726964 A EP 08726964A EP 2134314 A1 EP2134314 A1 EP 2134314A1
Authority
EP
European Patent Office
Prior art keywords
oil
phase
added
minutes
mixed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08726964A
Other languages
German (de)
English (en)
Inventor
Guerry L. Grune
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP2134314A1 publication Critical patent/EP2134314A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755—Gymnosperms [Coniferophyta]
    • A61K8/9767—Pinaceae [Pine family], e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/26—Optical properties
    • A61K2800/262—Transparent; Translucent

Definitions

  • This invention relates to new and useful ultraviolet radiation protective agents that can be used as beneficial sunscreens and sun-blocks in various compositions or formulations, • specifically those of a high SPF value (15-30, or greater).
  • the compositions contain only ingredients derived directly from naturally earth-occurring substances and offer enhanced protection.
  • a specific test methodology biological based is available to determine not only if the substances and resulting composition possess endocrine disrupters, but also determines the relative strength or concentration of the endocrine disrupter in a specific formulation.
  • UV-B region Ultraviolet radiation of wavelengths between about 290 nm and 320 ran (UV-B region) has been known to rapidly produce damaging effects on the skin including reddening or erythema, edema, blistering or other skin eruptions in more severe cases. Prolonged or chronic exposure to radiation in this wavelength range has been associated with serious skin conditions such as actinic keratoses and carcinomas. In recent years, concern has also been expressed regarding ultraviolet radiation of wavelengths above 320 nm (UV-A region) and the adverse effects of such radiation on human skin.
  • the radiation between 320 and 400 nm also contributes to the premature aging of the skin.
  • recent studies indicate that chronic sun exposure limits the immuno-response of the skin.
  • a tan will offer some protection against burning but that the tan is quite ineffectual against many other types of solar damage and there is no evidence that a tan increases immuno- responsive function in human skin.
  • patent 5,824,659 by Strickland and coworkers is that mono and polysaccharide extracts found in all Aloe plants, normally removed during carbon adsorptive processing, is capable of providing cytoprotection to the mammalian skin. This extract boosts the immune system response of the skin, thereby significantly reducing the risk to various forms of skin cancer. There is strong evidence to suggest that this beneficial effect translates to skin in most mammals, thereby the present invention provides a possible preventative formulation for animals in zoos or other habitats where UV exposure could also be hazardous to the animals' health.
  • UV protective product that has the following attributes: protection in the UV-A and UV-B long range and short range ultraviolet radiation ranges; maintenance of coverage, i.e., waterproof or at least water resistant and perspiration proof; application and use convenience, i.e., ease of application, invisibility, non-staining and non- greasy; and freedom from irritation as a result of its ingredients, in particular, its active sunblock or sunscreen ingredients should also be void of any known or suspected endocrine disrupters. Recent interest in this area includes some concerns over the irritancy and sensitization problems in addition to the endocrine disruptive nature that may occur in some individuals utilizing sunscreen products with high SPF values containing organic sunscreen agents.
  • the UV protective product could also include known cytoprotective oligosaccharides from aloe barbadensis Miller preventing damage to the skin immune system caused by harmful UV radiation.
  • "Cold-pressed" Aloe which contains the beneficial oligosaccharides and provides an emollient base for the UV protective formulation is possibly the best known choice as a cytoprotective agent that inhibits the loss of skin immuno- competency induced by ultraviolet radiation, as this agent is readily available and comparably inexpensive.
  • amino-acids vitamins or pro-vitamins, carotenoids, nucleo- derivatives, and vegetable extracts
  • said aminoacids comprise tryptophan, histidine, phenylalanine, tyrosine
  • the essential oils of frankincense and rosemary have been found to work effectively and synergistically in strengthening the neuromuscular response of patients who are exposed to its scent in combination with compositions of the present invention.
  • the sun protection factor is the ratio of the amount of exposure (dose) required to produce a minimal erythema reaction in protected skin to the amount required to produce the same reaction in unprotected skin.
  • the absolute dose differs for each human and for each mammal, and is largely dependent on genetic predisposition and ethnic origin of the human. If a human or other mammal would normally require ten minute exposure to sunlight to develop a minimal erythema reaction, then using an SPF 15 sun-block should allow for tolerance of up to 150 minutes of sunlight before developing a minimal erythema. Relatively recent public awareness of the problems of exposure to sunlight has led to a demand for sun-block products with high SPF values, i.e., at or above SPF 8.
  • Essential oils including specifically frankincense and rosemary have been shown to possibly have immuno-enhancing properties, as determined by Kinesiologist Dr. John Schmidt of Triangle Wellness Center at 182 Wind Chime Ct. Ste. 203 Raleigh, North Carolina 27615. This was determined by a strengthening in neuromuscular response using scent (aroma) testing of these essential oils. The testing was performed both together with compositions of the present invention and alone.
  • the formulations of the present disclosure contain ingredients which absorb or quench free radicals so that they can not further damage the cells of the skin.
  • the compositions contains ingredients known to boost carotenoid levels, including cold-pressed aloe vera gel and beta glucan, as well as Vitamins C & E, which bind with carotenoids to further boost anti-oxidant levels in the skin. More than 600 carotenoids have been identified in nature but less than 50 are abundant in the human diet.
  • carotenoids are found in the blood and known to be important in human health
  • b-carotene is found in the blood and known to be important in human health
  • a-carotene is found in the blood and known to be important in human health
  • free radicals are associated with carotenoids with their action as antioxidants, that is, they protect cells and tissues from the effects of free radicals.
  • Carotenoids are not soluble in water and thus would be added to the water/aloe phase of the present compositions within this disclosure.
  • Biophotonic scanning methodology allows for current and future development of formulations that are the most comprehensive, scientifically accepted and proven means for providing immuno-enhancing protection from free radical generation due to UV radiation from the sun.
  • additional (other than carotenoid) anti-oxidant wavelength specific compound concentrations can also be measured. This transformation, from qualitative to quantitative measurement of the anti-oxidant levels in any individual's skin, makes it possible to determine the effectiveness of any current or future formulation specifically designed to guard from overexposure to the sun's harmful radiation.
  • Free radicals are scavenged by anti-oxidants which equates to lower exposure to cytotoxic compounds and the ability to maintain healthy skin cells and tissue without suppression of the immune function associated with the same skin cells and tissue.
  • This technique including measurement and design of new and better sunscreen and sunblock formulations is also a part of the present disclosure.
  • SUMMARY OF THE DISCLOSURE This invention relates to new and useful ultraviolet radiation protective agents in combination with lotions, cremes, pastes, sprays, Hp balms, etc.
  • compositions include enhanced protection by providing cytoprotective additives (derived from a single pure aloe source) for mammalian skin while also providing avoidance from endocrine disrupting agents. It has been determined at least as early as July 2001, that sunscreen agents used in almost all currently marketed and sold ultraviolet protective compositions are essentially void of any cytoprotective agents and contain suspected or documented endocrine disruptive additives in both the active and non-active ingredients.
  • the invention adopts a relevant bioassay (or test method), which can both detect these chemicals (endocrine disrupters), as well as provide a relevant estimate of their endocrine disrupting potency.
  • sunscreen compositions containing sunscreen agents that overcome the disadvantages of heretofore available compositions and to provide non-endocrine disruptive, adequate, safe protection for mammalian skin.
  • cartotenoids and a biophotonic scanner to optimize (for cost and effectiveness) anti- oxidant concentrations within these unique compositions is also a part of this disclosure.
  • Another desirable portion of this invention addresses the potential risks and disadvantages, provides a viable and economically attractive alternative to the present commercial market, and proposes a new and safer rating system to rank these products for the consumer.
  • Another desired feature of this invention is to provide a method and the know-how relating to developing an all-natural/derived directly from naturally earth-occurring substances ingredient based dispersion of inorganic sun-block agents that will ensure an SPF value of at least 15 or greater.
  • the dispersion itself must not have any endocrine disrupting agents or known toxins within the composition.
  • the sunblock should also be translucent or transparent upon application to human skin.
  • the compositions of the present inventive compositions include the use of test methods for determining whether there are any endocrine disrupting ingredients, active or inactive, in this sunscreen or sun-block compositions or any other composition. This includes adopting a test method (Applied-Kinesiology) for determining the impact that the composition has on the wearer's neuro-muscular response.
  • Another attribute of the invention includes meeting all ECOCERT standards for natural products. These standards provide impartial, independent scientific expertise ensuring reliability of claims to be 'all-natural' in regards to ingredients and formulations.
  • sunscreen and sun-block compositions containing inorganic sun-block agents or known non-endocrine disruptive sunscreen agents as the active ingredients. More particularly, the present invention relates to sun-block compositions containing zinc oxide and, optionally, titanium dioxide of preferred particle size ranges, and in preferred amounts and ratios.
  • sun-block agents together with preferably specifically cold-pressed aloe that contains an oligosaccharide of molecular weight of approximately 1-5,000 daltons that is glucose rich and also contains mannose which inhibits the loss of skin immuno-competency form the basis of a novel protective UV formulation. It has become evident that cold-processed aloe that is processed within 45 minutes of harvesting contains about 200 biologically active agents. The synergistic effect of all of these agents is desirable and preferred to further enhance the cytoprotective ability inherent in aloe plant extract.
  • compositions of the present disclosure permit the use of much lower amounts of the sunscreen active ingredients than previously achievable while still achieving desired and very high SPF values for the compositions without the unsightly whiteness which occurs in prior sunscreen compositions.
  • Concentrations of inorganic metal oxides above about 5% has heretofore presented whitening which to some consumers is unacceptable.
  • concentrations of zinc oxide and possibly titanium dioxide may also be used without incurring a whitening effect, e.g., even up to 25% each, with acceptable appearance.
  • our invention does not rely upon the use of hydrophilic titanium dioxide preparations nor are energy intensive processes such as powder milling, nor are organic active sunscreens required for high efficacy.
  • the inorganic metallic oxides with aloe barbadensis Miller (preferably aloe barbadensis- Miller-Stockton - a single species) and purified water (preferably deionized or distilled) to provide a dispersion that contains ingredients that are ecocertified and void of any known endocrine disrupters.
  • aloe barbadensis Miller preferably aloe barbadensis- Miller-Stockton - a single species
  • purified water preferably deionized or distilled
  • compositions of this invention include emulsions containing at least the following components:
  • an inorganic metallic oxide sun-block agent including glass microspheres
  • b a non-endocrine disrupting or cytoprotective emulsifier or mixtures thereof
  • c a carrier oil component comprising an essential oil which is endocrine disruptive, with SPF boosting capabilities and
  • d at least one emollient, where the emollient may be the cytoprotective emulsifier of (b) above or another constituent that allows for providing even spreading and film forming of the composition onto the skin and aids in keeping water from leaving the stratum corneum e.
  • additional SPF boosting additives that are non-endocrine disruptors including gamma oryzanol.
  • cytoprotective refers to the ability to protect cells from becoming pre-cancerous or cancerous.
  • the emollient is preferably aloe as it is "cold pressed" or an extract of aloe that is currently removed during normal processing and recovered by some means.
  • the aloe or its extract may not provide sufficient emulsification based on the remaining ingredients of the composition. It has since been determined that a single species of aloe is preferred and best for providing a healthy and well dispersed product with the highest known concentrations of cytoprotective agents - aloe barbadensis Miller-Stockton. It is possible that the use of a natural product such as; Polyglyceryl-3 Polyricinoleate , for example, Dermofeel ® PR, manufactured by Dr.
  • Straetmans ® of Hamburg, Germany or Dermofeel ® GDI - glyceryl diisostearate, or Eumulgin SG - sodium stearoyl glutamate - and Emulgade PL 68/50 - a mixture of alkylpolyglucoside and cetyl stearyl alcohol and aribinogalactan and ethyl macadamiate) may all enhance the dispersion of the inorganic sun-block agents in the formulation and this is considered part of the present invention.
  • compositions of this invention provide formulations having an SPF of at least 10, with titanium dioxide, zinc oxide, or a combination of the two (with or without silica or silicon dioxide and/or cosmetic microspheres), with either a coated or uncoated hydrophilic surface, at concentration levels of at least 4% and preferably at least 14% to reach SPF 15 or greater.
  • the compositions of this invention exhibit extremely efficient uses of sunscreen components, particularly zinc oxide.
  • Zinc oxide (INCI: zinc oxide) Absorbs both UVA and UVB rays of ultraviolet light and can be used in ointments, creams, and lotions to protect against sunburn and other damage to the skin caused by ultraviolet light.
  • UVA and UVB absorber It is the broadest spectrum UVA and UVB absorber that is approved for use as a sunscreen by FDA, and is completely photostable. Additionally, since zinc oxide has antimicrobial and antifungal activities, it is the number one active ingredient recommended by pediatricians for the treatment of diaper rash. Alternatively, higher levels of preferably micronized titanium dioxide or zinc oxide can be used if ultramarine pigments are added to the composition. These pigments are known to eliminate the whiteness and poor spreadability of currently available compositions. For the purposes of this invention, however, these pigments must be known to be non-endocrine disruptive as well as to not interfere with the cytoprotective influence of the oligosaccharide aloe extract.
  • the invention makes use of uncoated particles (no surface treatment) of zinc oxide and/or titanium dioxide, unique formulation procedures must be followed to ensure proper dispersion.
  • These inorganic agents must be either pre-dispersed in an oil before being added to the composition or added to a water base. Acceptable oils and dispersion methods are discussed below in the working examples. With proper dispersion and the use of ultramarine pigments, the compositions, after initial coloring effects, are substantially invisible upon application to the skin.
  • Surface coated inorganic sunscreen can also be used, for example Z- cote HPl (ZnO coated with triethoxycaprylylsilane) and T-cote (TiO 2 coated with Dimethicone). These coatings or surface treatments allow for easier dispersion (normally in oil). However, because these coatings are objectionable to some consumers, compositions have been provided below with and without the use of surface treated ZnO and TiO 2 .
  • the present invention is directed toward a colored sunscreen emulsion comprising: (a) at least one ultramarine pigment that imparts a color other than white to the emulsion with a titanium dioxide or zinc oxide or possibly fumed or fused silica or even silicon dioxide or micronized glass cosmetic spheres so that when the emulsion is rubbed into the skin, the color substantially disappears; (b) at least one sunscreen active agent in an amount effective to protect skin against the actinic radiation of the sun — this preferably being ZnO or Z-Cote (micronized particles - preferably nanoparticle sized to assure transparency); (c) no known or suspected endocrine disrupting organic substances; (d) a cytoprotective substance such as a glucose-rich mannose-containing oligosaccharide obtained from and used with aloe barbadensis Miller as the at least one emulsif ⁇ er; and (e) sufficient water to form the other than a white colored emulsion; and sufficient disper
  • red raspberry seed oil and caneberry seed oil may be used as all natural SPF essential oils, hi the present disclosure an SPF of 30 or greater is enabled using red raspberry seed oil (in lieu of titanium dioxide) in a 4:1 ratio with ZnO (16%) concentration to raise the SPF of a base formulation to above SPF 30. With an 11% concentration of ZnO and red raspberry seed oil in a 4:1 ratio, a spray formulation with an SPF 22 was achieved.
  • the amount of the ultramarine pigment in the composition can range from about 0 to about 25 weight percent of the composition, and preferably from about 1 to about 5 weight percent of the final formulation.
  • the sunscreen emulsion can contain one or more additional ingredients, including emollients, waterproofing agents, dry-feel modifiers, insect repellants, antimicrobial preservatives and/or fragrances.
  • the present invention is also directed towards a method for protecting the skin against sunburn while eliminating possible endocrine disruption response of human organs comprising topically applying the sunscreen formulation, as described above, to the skin.
  • An advantage of the present invention is that it provides a sunscreen and a method for protecting against sunburn that enables the user to apply the sunscreen more completely and uniformly to the skin, thus providing more effective protection against skin damage and homogenously enhancing cytoprotection while eliminating endocrine disruptive organics, thus providing for long term health and safety in the presence of UV light.
  • Another advantage of the present invention is that it may provide a sunscreen with a color indicator which has a low fabric staining potential, and for which those stains that form can easily be removed from fabrics.
  • Still yet another advantage of the present invention is that it provides an optionally colored sunscreen and a method for protecting against sunburn that is more enjoyable for human use because of the attractiveness and appealing nature of the colored product which more closely matches the color of an individuals skin. For domesticated animals, the use of matching colors may also be appealing.
  • This invention allows for the use of ultrafine ZnO particles that are invisible when applied to human skin.
  • This "invisible” ZnO would be the primary and perhaps only sunblock “active” ingredient or could be combined with titanium dioxide and silica or silicon dioxide and cosmetic microspheres to enhance dispersion and therefore provide a higher SPF value.
  • These particles may be nanosized ( ⁇ 100 nm) or larger.
  • Another embodiment of the disclosure is that formulations were developed with ZnO that have no surface treatments and that create stable emulsions. Stability was determined by putting samples in an oven at 40 C for four months which is equivalent to 4 years of shelf life.
  • the SPF booster agents may include; broccoli seed oil, pomegranate seed oil, castor oil, castor oil derivatives, including Castor Isostearate Succinate, gamma oryzanol, and all cane seed oils, specifically raspberry seed oil as well as the previously documented silicone oils. Toxicity is determined by Lumi-Cell testing described below.
  • the UV-protective compositions of this invention yield highly effective ultraviolet (UV) blocking capabilities.
  • a typical titanium dioxide sunscreen composition of SPF 15 requires levels of titanium dioxide that impart a significant whitening effect to the skin; the compositions of this invention, minimize this disadvantage and are also economically viable to produce for commercial sale.
  • the composition of this invention include emulsions that are cosmetically superior to conventional inorganic preparations, including water-in-oil TiO 2 formulations, at equivalent SPF ratings, due to the method and type of dispersion described within this disclosure.
  • the compositions of this invention can be used for sun protection in casual daily wear or for facial products or in recreational situations. Because of the efficiency of the system, the inventive formulations are significantly better than any earlier developed compositions in that they do not allow for any endocrine disruptive agents to be included and meet or exceed the natural standards that the cosmetics industry is currently developing - including those of ECOCERT.
  • the formulation of this invention is intended to filter harmful UVA as well as harmful UVB radiation so that the skin is fully protected.
  • the required amounts required for application to the skin will vary.
  • the actual UV protective formulation will vary based on the environmental location, length of exposure, age, health and other factors involving individual mammals, such that the concentrations of non- endocrine disruptive UVA screens, UVB screens, SPF boosting agents, inorganic pigments, and cytoprotective agents will vary.
  • a new and unique claim of this invention is that the invention not only protects the wearer from the harmful effects of the sun but actually strengthens the wearer's 'Neuro-muscular response'.
  • One test method, 'Applied Kinesiology' has been used to test a user's neuro- muscular response to sunblock.
  • Applied kinesiology (AK) is a form of diagnosis using muscle testing as a primary feedback mechanism to examine how a person's body is functioning.
  • the compositions of the present invention have been tested according to this response and all patients have been "strengthened” in response to the inventive composition being applied to their skin.
  • This science is still evolving and is not fully understood and the evidence is empirical, but this testing has been performed over the course of 2 years (2004- 2005) at Dr. John Schmitt's office (Triangle Wellness Center at 182 Wind Chime Ct. Ste. 203 Raleigh, North Carolina 27615) and is evidentiary of the fact that the composition is, in fact, "immuno-enhancing.”
  • the immuno-response rating system could be a simple 0-10 value, with 10 indicating a substance within a UV-protective composition that is most beneficial to boosting skin cell immune responsiveness to carcinoma, melanoma, etc. (for instance).
  • Endocrines are essentially excretions from organs or glands.
  • the organs or glands continually function by discharging waste or at the least exchanging fluids from an inlet side to an outlet side. Any disruption in the natural behavior of an organ or gland could have a deleterious effect on the ability of that organ or gland to continue to function normally and can depress immunofunctionality.
  • the process of micronization refers to breaking up a substance into particles that are only a few micrometers in substance.
  • the groups of inorganic sun-block agents includes titanium dioxide, micronized titanium dioxide, zinc oxide, micronized zinc oxide, iron oxide, silicon dioxide, magnesium oxide, manganese oxide, silica, alumina, and aluminum oxides.
  • Cosmetic microspheres such as CM-111 AS produced by 3 M Corp of St. Paul, MN, can also be used as an inorganic sun-block agent.
  • boosting agents such as oils of safflower, sunflower, rice bran, eucalyptus, rosemary, peru balsam, olibanum, orange, almond, sesame, ylang ylang, jojoba, raspberry seed, pomegranate seed, or coconut
  • cocoate esters derived from coconut oil
  • Aloe Vera gel or juice preferably at 100% concentration from whole filleted aloe leaves, serve numerous purposes in the present invention, including acting as a dispersant, as an emollient, boosting the SPF value, and improving aesthetics, and is believed by many to have healthful benefits.
  • aloe vera is most commonly used externally to treat various skin conditions, and burns. Not only does it soothe the skin, ease pain and reduce inflammation, studies have been done to show that using aloe as a topical treatment for burns will help speed up the healing recovery process.
  • Many cosmetic companies are now adding this plant to products including makeup, soaps, sunscreens, shampoos and lotions, as well as any product that is created to soothe, protect and moisturize the skin.
  • aloe extract is full of vitamins, nutrients and minerals as well as biologically active substances including beneficial enzymes.
  • Terry Labs ® of Melbourne, FL manufactures a 10X-40X aloe vera gel product which is usable in the present invention.
  • 1OX is defined as 10 parts aloe to 90 parts water, while 4OX has four times the concentration of 10X, etc.
  • IOOX gel is preferable, such as that produced by Aloe #1 Laboratories of Ft. Lauderdale, FL, which is obtained directly from the aloe filet.
  • ECOCERT is a control and certification organisation, whose activities are governed accordingly by the public authorities and legislation.
  • ECOCERT is accredited for structure and procedures by COFRAC (French committee for accreditation), in accordance with guide standard ISO 65 (EN 45011), which requires independence, competence and impartiality. They work alongside associations to promote actions revolving around the environment and sustainable development.
  • COFRAC Federal Communications Commission
  • ISO 65 EN 45011
  • ECOCERT' s basic task consists in guaranteeing the rigorous respect of the applied standards on products, systems or services .
  • the issuance of the certificate acts as a security for the consumer or the user.
  • ECOCERT sets up standards in partnership with professionals, according to a tested methodology. These standards are based on objective and measurable criteria.
  • ECOCERT insures the conception of a inspection plan, aiming at quality, origin and traceability. Adherence to the standard remains a free and voluntary approach, bearing quality and ethical values requirements.
  • Ecocert defines a requirement level that is superior to the conventional regulation governing cosmetics, thereby guaranteeing the genuine practice of environmental respect throughout the production line, respect for the consumer and the promotion of natural substances of a superior ecological quality.
  • ECOCERT requirements relate to ingredients, processes, suppliers of all raw materials, packaging, and labeling. ECOCERT standards do not allow synthetic perfumes or dyes, silicones, glycols, carbomers, parabens, phenoxyethanol, emulsifiers such as PEG, or solvents such as propylene glycol.
  • compositions of this invention may, include one or more of a select group of anionic emulsifiers.
  • salts of certain fatty acids are useful in the formulations of this invention, preferably salts of saturated fatty acids and/or salts of straight-chain fatty acids.
  • Alkali metal salts, alkali earth metal salts and amine salts are more preferable for use in the compositions of this invention.
  • stearic acid and its salts are useful as emulsifiers in the compositions of this invention, while the use of isostearate salts tends to produce a composition which is not very efficient in the use of sunscreen.
  • Sodium borate is an example of a preferred salt.
  • Another potential emulsifier is glycerol oleate, and combinations thereof.
  • stearate or stearyl anionic emulsifiers that are useful in the compositions of this invention. While it is not fully understood why some salts of fatty acids result in an improved inventive composition, it is theorized that salts of straight-chain fatty acids, (the fatty acids having a relatively high melting point, above 70° C. or higher), are preferable due to their structure and how they resolve stearic hinderence and strain caused by introducing fine inorganic particles into polar and non-polar mediums.
  • the anionic emulsifiers should be present in the compositions of this invention in an amount from about 0.01 to about 10%, more preferably 0.1 to about 7% and most preferably from about 0.5 to about 5%. There may be additional emulsifiers present in the compositions of this invention. However it may or may not be necessary to include at least one anionic emulsifier in order to achieve the products of this invention.
  • the fatty acid salt emulsifiers may be added to the composition as the salts, or the salt may be formed in situ.
  • a carrier oil is useful in the compositions of this invention. There are a range of different carrier oils each with their own individual properties and suitability towards different treatments in aromatherapy.
  • the carrier oil which is more preferably an essential oil, should be present in the composition in an amount of between about 0.5% and about 40%. More preferably, it should be present in the amount of between about 5% and about 30%. Most preferably, it should be present in the amount of between about 15% and about 28%. All essential oils are non-endocrine disrupting.
  • oils of raspberry seed or any cane seed oil
  • pomegranate jojoba, rice bran, sesame, safflower, almond, sweet almond, eucalyptus, sunflower, peru balsam, rosemary, olibanum, orange, sunflower, ylang ylang, coconut, apricot kernel, avocado, borage, cocoa butter, evening primrose, grapeseed, hazelnut, kukui, macademia nut, olive, peanut, pecan, rose hip, bergamot, jasmine, neroli, patchouli, petitgrain, rose, vetiver, chamomile, mandarin, lavender, grapefruit, cypress, bay laurel, frankincense, clary sage, ginger, helichrysum, lemon, sandalwood, basil, black pepper, peppermint, geranium, wintergreen, thyme, tea tree, tangerine, spearmint, common sage, rosewood, pine, patchouli
  • an oil phase should contain at least two materials, the carrier oil or essential oil and a conventional emollient known to those of ordinary skill in the art as useful in sunscreen products, such as mineral oils, ester oils, vegetable oils, and the like.
  • a cold pressed aloe barbadensis Miller and specifically the Stockton species is to be substituted as an emollient or can be used in combination with the oils or emollients that are proven to be non-endocrine disrupting as well as not interfering with augmenting the cytoprotective enhancing effects of the known effective oligosaccharide aloe extract.
  • the emollient should be present in the formulation in a ratio to the carrier concentration of from about 1:1 to about 3:1, most preferably, about 2:1.
  • the carrier oil and the emollient should compose from about 2% to about 40% of the total composition weight.
  • a third element which should be present in the compositions of this invention is an inorganic sunscreen compound, such as titanium dioxide, zinc oxide or combinations thereof.
  • Possible other inorganics include the use of fused or fumed silica or even silicon dioxide.
  • titanium dioxide, zinc oxide, silica, silicon dioxide, or cosmetic microspheres should be used having a primary particle size of less than about 300 nm in diameter. Larger diameter particles could be used but should be combined to make the product transparent or at least translucent.
  • These inorganic compounds should be present in the composition in the amount of from about 2% to about 25%. More preferably, it should be present in the amount of from about 2% to about 15%.
  • the inorganic sunscreen compound should be oil dispersible, and may be present with or without surface coating.
  • the ratio of titanium dioxide or zinc oxide to the weight of the carrier oil and the emollient combined should be from about 0.0: 1 to about 1 :1. More preferably, the ratio should be between about 0.25:1 and 2:3, and most preferably 1:0.25.
  • the need for titanium dioxide may possibly be circumvented by the use of oils with SPF properties, such as red raspberry seed oil and pomegranate seed oil.
  • the base formulation of this invention may also be used as carrier compositions for active topical agents having dermatological effects, including depigmentation agents, anti-aging ingredients, anti-fungal agents, anti-microbial agents, insect repellents and the like.
  • depigmentation agents can include magnesium ascorbyl phosphate but only used in the final composition if shown not to be endocrine disrupters.
  • Anti-aging agents can include retinoid compounds and alpha-hydroxy acids again only if these agents are shown not to be endocrine disrupters.
  • Anti-fungal agents that can be included in the compositions of this invention include azole compounds including ketoconazole and the like again only if these agents are shown not to be endocrine disrupters.
  • Anti-microbial agents include triclosan, an unknown agent regarding cytotoxicity or endocrine disruption function.
  • Insect repellant fragrances can be included in the compositions of this invention again only if these agents are shown not to be endocrine disrupters.
  • Other products known to those of ordinary skill in the art may be delivered to the skin using the compositions of this invention.
  • compositions of this invention would then have minimally a multi-action capability, as they would contain both sunscreen/sunblocking agents and other actives for protecting, treating, and enhancing the immuno-responsive nature of the skin.
  • compositions of this invention can be incorporated into various cosmetic and personal care products such as hand and body lotions, oils, ointments, lip balm products, facial cosmetics and the like.
  • One of the major challenges in providing the composition of the present invention is to provide a non-toxic (meaning on contact, the composition will not kill cells), non-endocrine disrupting, high (15 or greater) SPF formulation that can be readily achieved in a manufacturing environment for a reasonable cost.
  • the use of aloe as both an emollient and a surfactant/dispersion agent together with either micronized ZnO, titanium dioxide, silicon dioxide, fluoropolymers, silica, etc. (inorganic or acceptable organic sun-block agents) in the manner outlined above is unique and novel.
  • SPF boosting agents that are neither toxic nor endocrine disrupters is also unique to this invention and has heretofore not been seriously considered or explored when combined specifically with untreated metal oxide particle surfaces and also with certain treated surfaces of the same metal oxides.
  • the aloe (INCI: Aloe Barbadensis) and specifically single species of aloe, seems particularly well-suited (with and without the use of glycerin) to provide an emulsion that is homogeneous and can achieve sufficient SPF values using 14% or more (by weight) of the inorganic sun-block agents.
  • Micronized sun-block agents are best for this emulsion as they provide the best surface area- volume ratio for proper wetting of the ZnO and other micronized inorganic/organic particles.
  • Green tea extract may be effective in reducing sunburn.
  • Green tea inhibits UVB- induced erythema response in the skin (redness reaction). At the same time it supports the production of melanin, the skin's own natural sunburn protection. Thus green tea helps reduce the risk of sunburn and boosts SPF.
  • Sucrose stearate is usually a white or light brown block or powder, with little or no smell and no taste. It is an exceptionally mild emulsif ⁇ er derived from sugar and coconut or palm oil. Sucrose stearate is made by combining sugar with stearic acid. Cane sugar is a sweetening agent and food which can act as a preservative and antioxidant, and stearic acid is a natural fatty acid derived from coconut or palm oil. Because it is made from vegetable sources it is completely biodegradable.
  • One commercially available form of sucrose stearate is Crodesta ® F- 160, manufactured by Croda of Buffalo, England. Esters of stearic acid are used to produce a pearly effect in shampoos, soaps, and other cosmetic products.
  • Hydrolyzed wheat protein is a protein from wheat which has been turned partly into water through hydrolysis.
  • coconut oil (ENCI: Cocos nucifera (Coconut) Oil) is also excellent as a skin moisturizer.
  • Hemp seed oil (INCI: Cannabis Satva (Sativa) Seed Oil) is used for the great effect it has on moisturizing and hydrating the skin, while bringing a host of other benefits such as recompensing for lower ceramide levels in the skin and thereby reducing the appearance of wrinkles.
  • Eumulgin® SG (INCI: Sodium Stearoyl Glutamate) is an anionic, powerful emulsifier especially interesting as it is EO-free and promotes the formulation of lamellar structures in oil/water emulsions when combined with suitable hydrophilic waxes. Due to the exceptional electrolyte compatibility Eumulgin® SG is key for concepts with high activity levels and / or water-soluble UV-filters.
  • Emulgade ® 68/50 (INCI: cetearyl alcohol & polyglucoside) is an ivory colored product with faint odor which is supplied in pellets. It is a non-ionic self-emulsifying base with consistency giving properties is suited for the preparation of cosmetic and pharmaceutical oil/water creams and lotions.
  • Lanolin is a thick natural moisturizer to soothe and protect skin. It is derived primarily from the oil glands in sheep's wool, also known as wool oil, wool wax, wool fat, or wool grease. Wool fat is a mixture of many different chemical compounds, including cholesterol and the esters derived from 'fatty' acids containing 18 to 26 carbon atoms. Lanolin is used in many skin formulas to prevent possible irritation from other oils. It functions as a salve and an emollient by sealing in your body's moisture, and is a natural water repellant. Lanolin forms an emulsion with water that's easily absorbed by the skin, softening it and preventing it from frying and cracking. It is used for dry skin, sunburn, and windburn, and may also boost SPF.
  • oils are used in commercial sunblocks as SPF boosters. Such oils may be effective at boosting SPF on their own in some cases, or in combination with other oils in other cases.
  • oils include sunflower oil, safflower oil, almond oil, rice bran oil, eucalyptus oil, sesame oil, orange oil, jojoba oil, rosemary oil, peru balsam oil, grape seed oil, coconut oil, red raspberry seed oil, black raspberry seed oil, pomegranate oil, etc.
  • Certain waxes may also have a positive SPF effect, including beeswax, orange wax, and the like.
  • Orange wax (INCI: Citrus Aurantium Dulcis (Orange) Peel Wax) has been found to be an excellent emollient, as well as containing phytosterols. These phytosterols are excellent co- emulsifiers which aid in stabilizing emulsions. Orange wax is also pondered to possess antimicrobial properties as well. Many silicone oils are suspected endocrine disrupters.
  • Beeswax is a product from a bee hive. Beeswax is secreted by honeybees of a certain age in the form of thin scales. It is a tough wax formed from a mixture of several compounds; Japan wax is another substitute.
  • Zenigloss® (INCI: Castor Isostearate Succinate, manufactured by Zenitech Corp ® of Old Greenwich, CT) is a natural liquid polymer of vegetable origin that is particularly suited for use in skin care products where an extended duration is desired such as liquid make-up products. It also provides good adhesion qualities for pigments and sunscreen films and when used in low solids emulsions it imparts a luxurious skin feel often associated with more expensive products. It has a high molecular weight which improves substantivity and puts gloss into a variety of applications and has pigment wetting and dispersion properties. Zenigloss serves in the present invention as an emulsifier and an SPF booster. It is natural and biodegradable and is easily formulated into finished products.
  • Zenigloss UP is a natural polymer of vegetable origin used where reduced odor and taste are required. It is an excellent wetting/dispersing agent for inorganic microfine sunscreen particulates and it helps to improve adhesion of high SPF very water resistant sunscreen products and gloss.
  • Gamma Oryzanol is a mixture of plant sterols and ferulic acid esters.
  • Rice bran oil (INCI: Oryza sativa (Rice) Bran Oil) is the principal source of gamma oryzanol, but it is also found in the bran of wheat and other grains, as well as various fruits, vegetables, and herbs.
  • the majority of gamma oryzanol used in nutritional supplements is harvested in Japan. It is also known as calclate, gamma-oz, gammariza, oryzanol, oz, and thiaminogen.
  • Gamma Oryzanol has been proven to have very strong antioxidant activity.
  • Vitamin C is a sugar acid with anti-oxidant properties. Ascorbate acts as an antioxidant.
  • Dermofeel ® PR Polyglyceryl-3 Polyricinoleate
  • Dermofeel® GDI Polyceryl Diisotearate
  • Dr. Straetmans of Hamburg, Germany is an oil component with good dispersability for color particles and an excellent adhesion strength. It is an non oxidizable, versatile applicable oil component of mediate to high viscosity. It is especially suitable to produce a resistant, long lasting film on the skin.
  • Ethyl Macadamiate (INCI: Ethyl Macadamiate) (for example, Floramac ® 10, by Floratech ® Americas of Chandler, Arizona) is the naturally derived ethyl ester of the free fatty acids produced by the complete saponification of Macadamia oil and offers excellent emolliency and skin feel. It is a dry emollient with high penetration, and has properties resembling silicone oil. Ethyl Macadamiate has SPF boosting properties and enhances the aesthetic pleasurability of the product. It serves as a substitute for silicon oil in the present invention. Unlike silicone oil, ethyl macadamiate is directly derived from naturally earth-occurring substances. Silicone oil is derived from synthetic components.
  • Arabinogalactin (INCI: Galactoarabinan) (for example, Laracare ® A200, manufactured by Lonza corp. of Basel, Switzerland) is a highly functional polysaccharide which serves as a natural, mild, non-irritating, readily biodegradable water soluble polymer capable of providing various benefits. It improves dispersion of inorganic sunscreen active ingredients and enhances SPF ratings. It provides film forming and skin tightening yielding an instant skin radiance and hair sheen effect. It also reduces transepidermal water loss (aids in moisturization). Studies have demonstrated its ability to minimize the appearance of fine lines and wrinkles, reduce transepidermal water loss (TEWL) and enhance alpha hydroxy acid (AHA) skin exfoliation without irritation.
  • TEWL transepidermal water loss
  • AHA alpha hydroxy acid
  • a dispersant is used.
  • Possible acceptable dispersants include cocoate esters, (glyceryl cocoate ethoxylate, for example 'Washout' ® manufactured by Heritage Products of Virginia Beach, VA); Polyglyceryl-3 Polyricinoleate (e.g. Dermofeel ® PR, manufactured by Dr. Straetmans of Hamburg, Germany); or glyceryl cocoate (e.g.
  • Imwitor ® 380 a partial glyceride of Caprylic, Capric, Citric, and Lactic acid, partially neutralized, or Imwitor ® 780k, a mixed ester of diglycerol with iso-stearic and succinic acid, manufactured by Sasol Olefins and Surfactants of Bad Homburg v.d. H ⁇ he, Germany).
  • Red Raspberry seed oil (INCI: Rubus Idaeus (Red Raspberry) seed oil) is a particularly functional oil in the present invention. Red raspberry seed oil possesses an exceptionally high proportion of alpha and gamma tocopherols (Vitamin E), vitamin A and omega-3 and omega- 6 fatty acids.
  • Red raspberry seed oil offers the skin broad spectrum protection from damaging UV-A and UV-B rays.
  • the SPF of red rapsberry seed oil has been found to be equal to that of titanium dioxide and has been rated to have an SPF as high as 28-50.
  • Red raspberry seed oil has more pronounced anti-inflammatory properties than avocado (INCI: Persea gratissima (Avocado) Oil), grapeseed, hazelnut and wheatgerm oils and may prove to be most effective oil to use in the treatment of eczema, psoriasis and other skin conditions.
  • Raspberry seed oil is also high in ellagic acid.
  • Ellagic acid is a polyphenol antioxidant found in numerous fruits and vegetables. All caneseed oils exhibit some levels of ellagic acid and therefore are beneficial in the formulations of the compositions of the present disclosure.
  • Pomegrante oil is also beneficial in the present invention.
  • Pomegranate seed oil nourishes, moisturizes and improves skin elasticity.
  • Pomegranate seed oil is high in lipids including pucinic acid.
  • Pomegranate seed oil can be effective in treating dry skin, eczema, psoriasis and sunburned skin. Its high polyphenol content makes it a strong anti-oxidant and adds to its stable shelf life.
  • Pomegranate seed oil contains conjugated fatty acids which gives it strong anti-inflammatory properties and makes it a highly beneficial addition to formulations intended to reduce swelling and ease muscular aches and pains. Studies have shown that pomegranate oil is effective at killing cancer cells when applied topically.
  • Arrowroot powder is the dried root of the arrowroot plant. It is a large perennial herb of genus Maranta found in rainforest habitats.
  • Tapioca also known as Cassava or Manioc, is a root or tuber extract. Its starch is found in the cells of the tubers.
  • Vitamin E oil (INCI: Tocopherol), is a fat-soluble vitamin in eight forms that is an important antioxidant. Vitamin E is often used in skin creams and lotions because it is believed to play a role in encouraging skin healing and reducing scarring after injuries such as burns. Natural vitamin E exists in eight different forms or isomers. Each form has its own biological activity, the measure of potency or functional use in the body. For the present invention, the most stable forms of Vitamin E are desired. Beta Carotene is an anti-oxidant and as such can be useful for curbing the excess of damaging free radicals in the body.
  • Beta-carotene is composed of two retinyl groups, and is broken down in the mucosa of the small intestine by beta-carotene dioxygenase to retinol, a form of vitamin A.
  • Carotene can be stored in the liver and converted to vitamin A as needed, thus making it a provitamin.
  • Carotene is an orange photosynthetic pigment and is responsible for the orange color of the carrot and many other fruits and vegetables. In the present invention it can serve an aesthetic purpose of enhanced coloration to improve transparency on the skin. Iron oxide can serve a similar purpose. Long-term supplementation with beta-carotene may reduce UV-induced erythema, and appears to modestly reduce the risk of sunburn in individuals who are sensitive to sun exposure.
  • Biovert® a product of Arch Chemicals ®.
  • Biovert® is a system of two linked preparations, which by themselves do not offer antimicrobial efficacy, but together offer anti-microbial efficacy. Biovert® mimics a naturally occurring antimicrobial-antioxidant protection system. When the two-part system is combined, a cascade of linked reactions takes place to generate antimicrobial products in situ.
  • the cascade is initiated by the action of the glucose oxidase enzyme in the presence of its substrate (glucose) and oxygen. This generates H 2 O 2 , which is used by the lactoperoxidase to catalyze the oxidation of F and SCN " anions, forming hypoiodite and hypothiocyanate which have antimicrobial activity. The result is rapid microbial cell death.
  • Other natural preservatives for use in the compositions of the present invention include tea tree and thyme essential oils, grapefruit seed extract (INCI: Citrus Grandis (Grapefruit) Seed Extract), and D- alpha Tocopherol Acetate (Vitamin E). Lactoperoxidase has been recognized as an effective antimicrobial and antibacterial agent.
  • One possible method for composing the sunblock composition of the present invention may be performed using a multi-vessel method, in which the oil and aloe or water phases are individually prepared. This process produces a smooth, uniform, white to light ivory emulsion that is satisfactory when the inorganic particles are sufficiently dispersed to provide desired SPF values.
  • uncoated inorganic sunscreen products When uncoated inorganic sunscreen products are used, they must be pre- dispersed before addition into the composition. When combined with ultramarine pigments, the color will change and may also provide a clear appearance (using the micronized inorganics) as the composition is applied to the skin.
  • phase A an aloe pre-mix
  • phase A an aloe pre-mix
  • surface treated or untreated zinc oxide is sprinkled and mixed until free from lumps.
  • a dispersant such as glyceryl cocoate or Dermofeel ® or Eumulgin ® and Emulgade ® and aribinogalactan ® is added, as well as glycerin.
  • the dispersant or emulsifier or emollient of the composite is added and mixed until completely uniform.
  • the pre-mix is kept agitated and cool (room temperature or below) until use.
  • phase B An oil pre-mix (“phase B”) is prepared separately in another vessel.
  • An oil for example raspberry seed oil, is mixed with a dispersant (for example Dermofeel ®).
  • This phase should be mixed with a homogenizer of preferably at least approximately 10,000 RPM until homogeneous. It is preferable to perform the mixing at room temperature or below.
  • phase C the inorganic sunscreen materials are then dispersed into an oil, for example rice bran oil ("phase C"). This phase is homogenized until the sunscreen material is completely dispersed, while heating the compound to 80° C. The temperature should then be maintained at 80° C, while the contents phase B described above are added and homogenized into the composition. If a coated sunscreen product such as z-cote ® HP-I is used, this phase is unnecessary and the sunscreen material can be added during the oil phase described below.
  • oil for example rice bran oil
  • the combined phases B and C are added to a clean, sanitized, and dry vessel, preferably stainless steel, with a sweep mixer and a rotosolver or equivalent high sheer mixing device (10,000 RPM) at 80° C. While the mixing device is operating, an "oil phase" is prepared by adding one or more of the following ingredients: one or more oils, a dispersant, and an emollient. Mixing should continue for 5-10 minutes until homogeneous, while temperature is maintained. One or more waxes and/or an emulsifier such as stearic acid is then added. Mixing should continue for 10-15 minutes. Hydrolyzed wheat protein can then be optionally added. Mixing continues for 5 minutes.
  • Another emulsifier is then optionally added, for example sucrose stearate. Mixing continues at least another 5 minutes.
  • Gamma oryzanol is optionally added and mixing continues for 15 minutes.
  • SPF ingredients e.g. glass microspheres, titanium dioxide
  • Beta Carotene and/or Vitamin E are optionally added, and mixing continues 5 minutes or until homogeneous.
  • a "water phase” is prepared in a separate vessel, preferably a clean, sanitized, and dry stainless steel vessel, equipped with a rotosolver or equivalent high shear mixing device (10,000 RPM). Deionized water is added and heated to 80° C. The following ingredients are added: glycerin, carrageenan, arabinogalactin, aloe, and/or the contents of "phase A" described above. The contents are mixed for 30 minutes or until homogeneous while maintaining temperature of 80° C.
  • Milk powder is optionally added and mixed for 15-20 minutes or until homogeneous.
  • the rotosolver is turned off and the sweep mix set to low, as contents cool to 38-40° C.
  • the rotosolver is then turned on and a preservative, such as Biovert ®, (glucose and lactoperoxidase and glucose oxidase) is added.
  • a preservative such as Biovert ®, (glucose and lactoperoxidase and glucose oxidase) is added.
  • Biovert ® glucose and lactoperoxidase and glucose oxidase
  • Fragrance can then be added. Quality analysis can then be performed on the batch, and after proper storage of the compound, equipment can be cleaned for future batches.
  • the best method is to add the metal oxide to water with emulsifiers and then create a water in oil (w/o) system.
  • UV-protective formulation would safely block and/or screen UV light, enhance the immune responsiveness of the skin in the absence or presence of UV, and ensure the user that there is no toxic substance present.
  • boosting agents should also not be toxic (cell-killing). It is likely that many natural oils and perhaps derivatives of other natural occurring substances (such as essential oils of safflower, sunflower, rice bran, eucalyptus, rosemary, peru balsam, olibanum, orange, almond, sesame, ylang ylang, jojoba, or coconut) that can provide dispersion capabilities to enhance or boost SPF values may also be determined to be toxic free and are therefore also part of this disclosure. It has also been suggested that to increase SPF values for both in vivo and in vitro testing, film forming properties are important. The following film forming agents may also be used in the formulations and resulting compositions of the present disclosure: wheat protein extract, silk protein, galactoarabian, marine collagen, pea extract, purcellin oil, preen oil, and wild mango butter.
  • Bentonite can be used to boost SPF values.
  • Colloidal Bentonite contains the active constituent montmorillonite super-refined with demineralized water as a vehicle.
  • Aloe Vera gel serves numerous purposes in the present disclosure, including acting as a dispersant, as an emollient, boosting the SPF value, and improving aesthetics, and is believed by many to have healthful benefits.
  • compositions of this disclosure may be delivered to the skin using the compositions of this disclosure. Proper wetting is more readily achieved and results in long term stability when homogenization is employed.
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% uncoated Z-cote; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6 kg is prepared.
  • Phase B is prepared by mixing Dermofeel GDI ® (glyceryl diisostearate) and red raspberry seed oil in equal proportions. A total of 0.4 kg is prepared.
  • Phase C is prepared by mixing Z-cote and rice bran oil in a 1.5:2 ratio. 22 g of rice bran oil are homogenized with 16 g of z-cote, and the combination is homogenized at 80° C. "Phase B” is then homogenized into “Phase C” while maintaining temperature of 80° C.
  • the oil phase is prepared in a separate vessel.
  • the combined phases B and C are mixed with a rotosolver (10,000 RPM) at 80° C.
  • the following are added: 0.2 g coconut oil; 3 g raspberry seed oil; 4 g Zenigloss ® (Castor Isostearate Succinate); 3 g ethyl macadamiate.
  • the contents are mixed for 5-10 minutes at 80° C.
  • 3 g of glycerin are added, as well as the 0.6 kg of "phase A” described above and 0.3 kg of aloe gel 10OX, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. 3 g of aloe gel IOOX are added and mixed for an additional 10 minutes. 2 g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16 g of tapioca starch is added and mixed for an additional 10 minutes. 1 g grapefruit seed extract is added and mixed for an additional 10 minutes. 0.1 g ascorbyl palmitate is added and mixed for an additional 10 minutes.
  • 0.2 g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: 1 g of Biovert® substrate (glucose), and 0.05g Biovert® enzyme (lactoperoxidase glucose). When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • SPF skin protection factor
  • Phase A is prepared with the following proportions: 71.43% Aloe (IOOX concentration); 7.14% uncoated Z-cote; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.3kg are prepared.
  • Phase B is prepared by mixing Dermofeel GDI ® (glyceryl diisostearate) and red raspberry seed oil in equal proportions. A total of 0.4 kg is prepared.
  • Phase C is prepared by mixing Z-cote and rice bran oil in a 1.5:2 ratio. 22g of rice bran oil are homogenized with 16g of z-cote, and the combination is homogenized at 80° C. "Phase B” is then homogenized into “Phase C” while maintaining temperature of 80° C. The oil phase is prepared in a separate vessel. The combined phases B and C are mixed with a rotosolver (10,000 RPM) at 80° C. The following are added: 0.2g coconut oil; 3g raspberry seed oil; 5g Zenigloss ®; 3g ethyl macadamiate. The contents are mixed for 5-10 minutes at 80° C.
  • Ig stearic acid 0.2g orange wax
  • 2g beeswax The following are added: Ig stearic acid; 0.2g orange wax; 2g beeswax.
  • Ig stearic acid 0.2g orange wax
  • 2g beeswax Mixing continues for 10-15 minutes at 80° C Ig of wheat protein is added, and mixed for 5 minutes at 80° C Ig of sucrose stearate (Crodesta F- 160) is added and mixed for 5 minutes at 80° C 0.2g of gamma oryzanol is added and mixed for 15 minutes. 3g of glass microspheres are added and mixed for 15 minutes.
  • O.lg of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous.
  • the rotosolver is turned off and the sweep mix set to low.
  • the batch is cooled to 38-40° C
  • the rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% uncoated Z-cote; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.3kg are prepared.
  • Phase B is prepared by mixing Dermofeel ® (glyceryl diisostearate) and red raspberry seed oil in equal proportions. A total of 0.4kg is prepared.
  • Phase C is prepared by mixing Z-cote and rice bran oil in a 1.5:2 ratio. 22g of rice bran oil are homogenized with 16g of z-cote, and the combination is homogenized at 80° C. "Phase B” is then homogenized into “Phase C” while maintaining temperature of 80° C.
  • the oil phase is prepared in a separate vessel.
  • the combined phases B and C are mixed with a rotosolver (10,000 RPM) at 80° C.
  • the following are added: 0.2g coconut oil; 3g raspberry seed oil; 6g Zenigloss ®; 3g ethyl macadamiate.
  • the contents are mixed for 5-10 minutes at 80° C.
  • the following are added: 0.2g orange wax; 2g beeswax.
  • Mixing continues for 10-15 minutes at 80° C.
  • Ig of wheat protein is added, and mixed for 5 minutes at 80° C.
  • Ig of Crodesta F-160 is added and mixed for 5 minutes at 80° C.
  • 0.2g of gamma oryzanol is added and mixed for 15 minutes.
  • a separate water phase 20.87 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.3kg of "phase A" described above and 0.3kg of aloe gel 10OX, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. 2g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes.
  • the temperature is maintained at 80° C and mixed for 15-20 minutes.
  • the rotosolver is turned off and the sweep mix set to low.
  • the batch is cooled to 38-40° C.
  • the rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • the resulting SPF of the composition of Example III above when measured in vitro was 34.33 and the composition was aesthetically satisfactory and stable.
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% uncoated Z-cote; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
  • Phase B is prepared by mixing Dermofeel ® and rice bran oil in equal proportions. A total of 0.4kg is prepared. “Phase B” is then homogenized with 0.16g of zinc oxide while maintaining temperature of 80° C.
  • the oil phase is prepared in a separate vessel.
  • the phase B is mixed with a rotosolver (10,000 RPM) at 80° C.
  • the following are added: 0.2g coconut oil; 2g jojoba oil; 2g pomegranate seed oil; 8g rice bran oil; 2g raspberry seed oil; 7g Zenigloss ®.
  • the contents are mixed for 5- 10 minutes at 80° C.
  • the following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax.
  • Mixing continues for 10-15 minutes at 80° C Ig of wheat protein is added, and mixed for 5 minutes at 80° C. 1 g of Crodesta F- 160 is added and mixed for 5 minutes at 80° C.
  • gamma oryzanol 0.2g is added and mixed for 15 minutes. 5g of glass microspheres are added and mixed for 15 minutes. 0.0001 g of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous.
  • a separate water phase 25.87 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.6kg of "phase A" described above and 0.3kg of aloe gel 10OX, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. 4g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes. O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes.
  • 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% uncoated Z-cote; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
  • Phase B is prepared by mixing Dermofeel ® and red raspberry seed oil in equal proportions. A total of 0.4kg is prepared.
  • Phase C is prepared by mixing Z-cote and rice bran oil in a 1.5:2 ratio. 22g of rice bran oil are homogenized with 16g of z-cote, and the combination is homogenized at 80° C. "Phase B” is then homogenized into “Phase C” while maintaining temperature of 80° C.
  • the oil phase is prepared in a separate vessel.
  • the combined phases B and C are mixed with a rotosolver (10,000 RPM) at 80° C.
  • the following are added: 0.2g coconut oil; 2g raspberry seed oil; 7g Zenigloss ®.
  • the contents are mixed for 5-10 minutes at 80° C.
  • the following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax.
  • Mixing continues for 10-15 minutes at 80° C Ig of wheat protein is added, and mixed for 5 minutes at 80° C Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C.
  • 0.2g of gamma oryzanol is added and mixed for 15 minutes.
  • Ig of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous.
  • Example VI The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C The rotosolver is turned back on for the addition of the preservative: lg of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Example VI The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C The rotosolver is turned back on for the addition of the preservative: lg of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Example VI Example VI
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
  • the oil phase is prepared in a separate vessel. The following are added: 6g glyceryl cocoate ethoxylate; 0.2g coconut oil; 2g jojoba oil; 2g avocado oil; 1Og pomegranate seed oil; 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax. Mixing continues for 10-15 minutes at 80° C Ig of wheat protein is added, and mixed for 5 minutes at 80° C Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 0.2g of gamma oryzanol is added and mixed for 15 minutes.
  • O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes.
  • 0.2g milk powder is added and mixed for an additional 10 minutes.
  • the temperature is maintained at 80° C and mixed for 15-20 minutes.
  • the rotosolver is turned off and the sweep mix set to low.
  • the batch is cooled to 38-40° C
  • the rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
  • Phase B is prepared with equal proportions of Dermofeel ® and rice bran oil. A total of 0.4kg is prepared.
  • the oil phase is prepared in a separate vessel. The following are added: The 0.4kg of phase B described above; 0.2g coconut oil; 2g jojoba oil; 2g pomegranate seed oil; 8g rice bran oil; 2g raspberry oil; 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax. Mixing continues for 10- 15 minutes at 80° C Ig of wheat protein is added, and mixed for 5 minutes at 80° C. Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 0.2g of gamma oryzanol is added and mixed for 15 minutes.
  • a separate water phase 25.87 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.6kg of "phase A" described above and 0.3kg of aloe gel 10X, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. Ig of aloe gel 1OX is added and mixed for an additional 10 minutes. 4g of arrowroot powder is added and mixed for an additional 10 minutes. 0.16g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes.
  • O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes.
  • 0.2g milk powder is added and mixed for an additional 10 minutes.
  • the temperature is maintained at 80° C and mixed for 15-20 minutes.
  • the rotosolver is turned off and the sweep mix set to low.
  • the batch is cooled to 38-40° C.
  • the rotosolver is turned back on for the addition of the preservative: lg ofBiovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
  • Phase B is prepared with equal proportions of Dermofeel ® and rice bran oil. A total of 0.4kg is prepared.
  • the oil phase is prepared in a separate vessel. The following are added: The 0.4kg of phase B described above; 0.2g coconut oil; 2g jojoba oil; 8g raspberry oil; 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax. Mixing continues for 10-15 minutes at 80° C Ig of wheat protein is added, and mixed for 5 minutes at 80° C. Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 0.2g of gamma oryzanol is added and mixed for 15 minutes. 4g of glass microspheres are added and mixed for 15 minutes. 16g of z-cote HPl is added and mixed for 15 minutes. Ig of titanium dioxide is added and mixed for 15 minutes. 0.000 Ig of beta carotene and O.lg of Vitamin E are added, and mixed for 5 minutes until homogeneous.
  • O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes.
  • 0.2g milk powder is added and mixed for an additional 10 minutes.
  • the temperature is maintained at 80° C and mixed for 15-20 minutes.
  • the rotosolver is turned off and the sweep mix set to low.
  • the batch is cooled to 38-40° C.
  • the rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
  • Phase B is prepared with equal proportions of Dermofeel ® and rice bran oil. A total of 0.4kg is prepared. The oil phase is prepared in a separate vessel. The following are added: The 0.4kg of phase B described above; 0.2g coconut oil; 2g jojoba oil; 2g avocado oil; 1Og pomegranate seed oil; 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax. Mixing continues for 10-15 minutes at 80° C. Ig of wheat protein is added, and mixed for 5 minutes at 80° C Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C.
  • 0.2g of gamma oryzanol is added and mixed for 15 minutes. 4g of glass microspheres are added and mixed for 15 minutes. 16g of z-cote HPl is added and mixed for 15 minutes. Ig of titanium dioxide is added and mixed for 15 minutes. 0.000 Ig of beta carotene and O.lg of Vitamin E are added, and mixed for 5 minutes until homogeneous.
  • O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes.
  • 0.2g milk powder is added and mixed for an additional 10 minutes.
  • the temperature is maintained at 80° C and mixed for 15-20 minutes.
  • the rotosolver is turned off and the sweep mix set to low.
  • the batch is cooled to 38-40° C.
  • the rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
  • the oil phase is prepared in a separate vessel. The following are added: The 6g of glyceryl cocoate ethoxylate; 0.2g coconut oil; 2g jojoba oil; 2g avocado oil; 1Og rice bran oil; 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax. Mixing continues for 10-15 minutes at 80° C Ig of wheat protein is added, and mixed for 5 minutes at 80° C Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 0.2g of gamma oryzanol is added and mixed for 15 minutes.
  • O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes.
  • 0.2g milk powder is added and mixed for an additional 10 minutes.
  • the temperature is maintained at 80° C and mixed for 15-20 minutes.
  • the rotosolver is turned off and the sweep mix set to low.
  • the batch is cooled to 38-40° C.
  • the rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
  • the oil phase is prepared in a separate vessel. The following are added: The 3g of glyceryl oleate; 0.2g coconut oil; 2g jojoba oil; 2g avocado oil; 1Og broccoli seed oil; 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax. Mixing continues for 10-15 minutes at 80° C. Ig of wheat protein is added, and mixed for 5 minutes at 80° C. Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 0.2g of gamma oryzanol is added and mixed for 15 minutes.
  • O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes.
  • 0.2g milk powder is added and mixed for an additional 10 minutes.
  • the temperature is maintained at 80° C and mixed for 15-20 minutes.
  • the rotosolver is turned off and the sweep mix set to low.
  • the batch is cooled to 38-40° C.
  • the rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
  • the oil phase is prepared in a separate vessel. The following are added: 3g of sunflower oil; 6g of glyceryl cocoate ethoxylate; 0.2g coconut oil; 2g of broccoli oil; 2g jojoba oil; 6g macadamia nut oil; 1Og Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 2g beeswax. Mixing continues for 10- 15 minutes at 80° C. 1 kg of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. Ig of glass microspheres are added and mixed for 15 minutes. 16g of z-cote HPl is added and mixed for 15 minutes. Ig of titanium dioxide is added and mixed for 15 minutes. 0.000 Ig of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous.
  • 0.2g milk powder is added and mixed for an additional 10 minutes. The temperature is maintained at 80° C and mixed for 15-20 minutes. The rotosolver is turned off and the sweep mix set to low. The batch is cooled to 38-40° C. The rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. Fragrance is then added: 0.2g rosemary; O.lg peru balsam oil; .02g frankincense. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
  • the oil phase is prepared in a separate vessel. The following are added: 3g of sunflower oil; 6g of glyceryl cocoate ethoxylate; 0.2g coconut oil; 2g Zenigloss ® UP; 8g of broccoli oil; 2g avocado oil; 2g jojoba oil; 8g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 2g beeswax. Mixing continues for 10-15 minutes at 80° C. Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 3g of glass microspheres are added and mixed for 15 minutes. 16g of z-cote HPl is added and mixed for 15 minutes.
  • gamma oryzanol 0.3g gamma oryzanol is added and mixed for 15 minutes. 1.5g of titanium dioxide is added and mixed for 15 minutes. 0.0001 g of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous.
  • a separate water phase 25.77 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.6kg of "phase A" described above, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. 0.1kg of aloe gel 1OX is added and mixed for an additional 10 minutes. Ig wood powder, Ig bentonite, and 2g of sodium bicarbonate are added and mixed for an additional 10 minutes. 0.08g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes.
  • O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes.
  • 0.2g milk powder is added and mixed for an additional 10 minutes.
  • the temperature is maintained at 80° C and mixed for 15-20 minutes.
  • the rotosolver is turned off and the sweep mix set to low.
  • the batch is cooled to 38-40° C.
  • the rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. Fragrance is then added: 0.2g rosemary; O.lg peru balsam oil; .02g frankincense. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
  • the oil phase is prepared in a separate vessel. The following are added: 3g of sunflower oil; 6g of glyceryl cocoate ethoxylate; 0.2g coconut oil; Ig Zenigloss ® UP; 4g of broccoli oil; 4g pomegranate seed oil; 2g jojoba oil; 6g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 2g beeswax. Mixing continues for 10-15 minutes at 80° C Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 2g of glass microspheres are added and mixed for 15 minutes.
  • 18g of z-cote HPl is added and mixed for 15 minutes.
  • 0.2g gamma oryzanol is added and mixed for 15 minutes.
  • Ig of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous.
  • Ig wood powder, 0.5g bentonite, and 0.5g of sodium bicarbonate are added and mixed for an additional 10 minutes.
  • 0.08g of tapioca starch is added and mixed for an additional 10 minutes.
  • 1 kg grapefruit seed extract is added and mixed for an additional 10 minutes.
  • O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes.
  • 0.2g milk powder is added and mixed for an additional 10 minutes.
  • the temperature is maintained at 80° C and mixed for 15-20 minutes.
  • the rotosolver is turned off and the sweep mix set to low.
  • the batch is cooled to 38-40° C.
  • the rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. Fragrance is then added: 0.2g rosemary; O.lg peru balsam oil; .02g frankincense. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.3kg are prepared.
  • the oil phase is prepared in a separate vessel. The following are added: 6g of glyceryl cocoate ethoxylate; 5g Zenigloss ® UP; 5g of broccoli oil; 2g avocado oil; 5g pomegranate seed oil; 2g jojoba oil. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 2g beeswax. Mixing continues for 10-15 minutes at 80° C. Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 4g of glass microspheres are added and mixed for 15 minutes. 16g of z-cote FIPl is added and mixed for 15 minutes.
  • gamma oryzanol 0.3g gamma oryzanol is added and mixed for 15 minutes. 0.000 Ig of beta carotene and O.lg of Vitamin E are added, and mixed for 5 minutes until homogeneous. Ig hydrolyzed wheat protein and mixed for 10 minutes until homogeneous.
  • a separate water phase 25.77 mL of water are heated to 80° C. 3g of glycerin are added, as well as the 0.3kg of "phase A" described above, and mixed with a rotosolver (10,000 RPM) for 30 minutes at 80° C. The water phase is then slowly added to the oil phase at 80° C. Mixing continues for 30 minutes. 0.1kg of aloe gel 1OX is added and mixed for an additional 10 minutes. Ig wood powder, 2g of arrowroot powder, and Ig bentonite are added and mixed for an additional 10 minutes. 0.08g of tapioca starch is added and mixed for an additional 10 minutes. Ig grapefruit seed extract is added and mixed for an additional 10 minutes.
  • O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes.
  • 0.2g milk powder is added and mixed for an additional 10 minutes.
  • the temperature is maintained at 80° C and mixed for 15-20 minutes.
  • the rotosolver is turned off and the sweep mix set to low.
  • the batch is cooled to 38-40° C.
  • the rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When inco ⁇ orated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
  • the oil phase is prepared in a separate vessel. The following are added: 6g liquid lanolin; 0.2g coconut oil; 2g avocado oil; 1Og pomegranate seed oil; 2g jojoba oil; and 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax; and Ig sodium borate. Mixing continues for 10-15 minutes at 80° C. Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 4g of glass microspheres are added and mixed for 15 minutes. 16g of z-cote HPl is added and mixed for 15 minutes. Ig titanium dioxide is added and mixed for 15 minutes.
  • gamma oryzanol 0.2g gamma oryzanol is added and mixed for 15 minutes.
  • Ig of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous.
  • O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes.
  • 0.2g milk powder is added and mixed for an additional 10 minutes.
  • the temperature is maintained at 80° C and mixed for 15-20 minutes.
  • the rotosolver is turned off and the sweep mix set to low.
  • the batch is cooled to 38-40° C.
  • the rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
  • the oil phase is prepared in a separate vessel. The following are added: 6g Sasol Imwitor ® 360; 0.2g coconut oil; 2g avocado oil; 1Og pomegranate seed oil; 2g jojoba oil; and 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax; and Ig sodium borate. Mixing continues for 10-15 minutes at 80° C. Ig of Crodesta F- 160 is added and mixed for 5 minutes at 80° C. 4g of glass microspheres are added and mixed for 15 minutes. 16g of z-cote HPl is added and mixed for 15 minutes.
  • Ig titanium dioxide is added and mixed for 15 minutes.
  • 0.2g gamma oryzanol is added and mixed for 15 minutes.
  • Ig of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous.
  • O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes.
  • 0.2g milk powder is added and mixed for an additional 10 minutes.
  • the temperature is maintained at 80° C and mixed for 15-20 minutes.
  • the rotosolver is turned off and the sweep mix set to low.
  • the batch is cooled to 38-40° C.
  • the rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared. The oil phase is prepared in a separate vessel. The following are added: 6g Sasol Imwitor ® 780K; 0.2g coconut oil; 2g avocado oil; 1Og pomegranate seed oil; 2g jojoba oil; and 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C.
  • O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes.
  • 0.2g milk powder is added and mixed for an additional 10 minutes.
  • the temperature is maintained at 80° C and mixed for 15-20 minutes.
  • the rotosolver is turned off and the sweep mix set to low.
  • the batch is cooled to 38-40° C.
  • the rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
  • the oil phase is prepared in a separate vessel. The following are added: 6g glyceryl cocoate ethoxylate; 0.2g coconut oil; 2g avocado oil; 3g pomegranate seed oil; 2g jojoba oil; and 14g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax; and Ig sodium borate. Mixing continues for 10-15 minutes at 80° C. Ig of Crodesta F-160 is added and mixed for 5 minutes at 80° C. 4g of glass microspheres are added and mixed for 15 minutes. 18g of z-cote HPl is added and mixed for 15 minutes.
  • titanium dioxide 1.5g is added and mixed for 15 minutes.
  • 0.2g gamma oryzanol is added and mixed for 15 minutes.
  • Ig of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous.
  • O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes.
  • 0.2g milk powder is added and mixed for an additional 10 minutes.
  • the temperature is maintained at 80° C and mixed for 15-20 minutes.
  • the rotosolver is turned off and the sweep mix set to low.
  • the batch is cooled to 38-40° C.
  • the rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Phase A is prepared with the following proportions: 71.43% Aloe (10OX concentration); 7.14% Z-cote HPl; 7.14% glyceryl cocoate ethoxylate; 14.29% glycerin. The combination is mixed until homogenized, at room temperature or below. A total of 0.6kg are prepared.
  • the oil phase is prepared in a separate vessel. The following are added: 6g glyceryl cocoate ethoxylate; 0.2g coconut oil; 2g avocado oil; 1Og rice bran oil; 2g macadamia nut oil; 2g jojoba oil; and 7g Zenigloss ®. The contents are mixed for 5-10 minutes at 80° C. The following are added: 2g stearic acid; 0.2g orange wax; 4g beeswax. Mixing continues for 10- 15 minutes at 80° C. Ig of Crodesta F-160 is added and mixed for 5 minutes at 80° C. 4.25g of glass microspheres are added and mixed for 15 minutes. 17g of z-cote HPl is added and mixed for 15 minutes.
  • titanium dioxide is added and mixed for 15 minutes.
  • gamma oryzanol is added and mixed for 15 minutes.
  • Ig of beta carotene and O.lg of Vitamin E Covoix-T are added, and mixed for 5 minutes until homogeneous.
  • O.lg ascorbyl palmitate is added and mixed for an additional 10 minutes.
  • 0.2g milk powder is added and mixed for an additional 10 minutes.
  • the temperature is maintained at 80° C and mixed for 15-20 minutes.
  • the rotosolver is turned off and the sweep mix set to low.
  • the batch is cooled to 38-40° C.
  • the rotosolver is turned back on for the addition of the preservative: Ig of Biovert® substrate, and 0.05g Biovert® enzyme. When incorporated, the rotosolver is turned off. Sweep mixing continues for 30 minutes.
  • Phase A (Water phase) is prepared with the following proportions: Pure aloe vera liquid/gel is prepared with 0.25% sodium bicarbonate and optionally 0.25% carrageenan. In a clean, sanitized and dry stainless steel vessel equipped with a homogenizer add, 69.95% pure aloe, 5.33% Glyceryl Cocoate, (a 50/50 blend of glycerine and glyceryl cocoate premixed at 80 deg C and mix until homogeneous).
  • Phase B (Oil Phase) In a clean, sanitized and dry stainless steel vessel equipped with a homogenizer add 2.67% - 3.67% Raspberry Seed Oil or Rice Bran Oil, optionally 1% Hemp Seed Oil and mix until homogeneous while heating (no greater than 80 degrees Cnetigrade). When Phase B is homogeneous and at the desired temperature (80 degrees Celsius or lower) add 3% Stearic Acid and mix until homogeneous. Continue mixing and cool Phase B to room temperature. Add 3% Ethyl Macadamiate, and mix until homogeneous.
  • Phase B When Phase B is homogeneous, add to Phase A. Mix (preferably with homogenizer) for 20- 30 minutes until homogeneous. (DO NOT allow batch to heat with mechanical heat from mixing-maintain at room temperature.) At room temperature add 0.5% Arabinogalactin and mix until homogeneous. Add 1% Biovert® Substrate, 0.05% Biovert® Enzyme, (Glucose & Lactoperoxidase & Glucose Oxidase ) and up to 2.5% of a natural fragrance and mix for 20- 30 minutes until homogeneous, maintaining batch at room temperature. At room temperature, if necessary add another 2% pure aloe as described above. This final step may or may not be useful scale-up and for defoaming and viscosity control purposes.
  • Phase A (Water phase) is prepared with the following proportions: Pure Aloe is prepared with water to achieve a pH of 5.5. Sodium bicarbonate 0.5% may be used in the aloe. In a clean, sanitized and dry stainless steel vessel equipped with a homogenizer add, 49.95% Pure Aloe, 20.00% water, 11.00% Zinc Oxide Z-Cote (with no coating), 1.5% Eumulgin SG® (Sodium stearoyl glutamate) and 2% Emulglade PL68/50 ® (Cetearyl Glucoside & Cetearyl Alcohol) Mix until homogeneous.
  • Phase B Oil Phase.
  • Phase B Oil Phase.
  • Phase B In a clean, sanitized and dry stainless steel vessel equipped with a homogenizer add 2.67% Raspberry Seed Oil and 1% Hemp Seed Oil and mix until homogeneous while heating to 80 deg.C.
  • Phase B When Phase B is homogeneous and at 80 degrees Celsius add 3% Stearic Acid, and mix until homogeneous. Continue mixing and cool Phase B to room temperature.
  • Phase B is homogeneous, add to Phase A and add 1.83% aloe. Mix with homogenizer for 20-30 minutes until homogeneous.
  • EXAMPLE XXIII Phase A (Water phase) is prepared in this order: Heat to 60 deg.C. Add 14.75% water, 32.85% Aloe Juice w/carageenan and baking soda, 0.5% laracare A 200® (aribinogalactan), 3% Eumulgin SG®, 1% Emulgade PL68/50®, 16% Zinc Oxide, 1% hydrolyzed wheat protein, 1% hydrolyzed wheat protein, 0.1% vitamin E, 0.1% ascorbic acid - vitamin C, 0.1% orange wax, 0.5% beeswax and 0% beta carotene. Homogenize water phase at 60 deg.C.
  • Phase B Oil Phase. Mix the following 2 ingredients together; 9% Rice Bran Oil and 0.2% Oryzinol. Heat to 70 C and slowly in order add the following while homogenizing: 5% Raspberry seed oil, 0.1% Hemp Seed Oil, 4% Ethyl Macadamiate, 2% stearic acid, 4% Zenigloss® gloss and 0% coconut oil. Mix at 60 deg.C until homogenous. Add oil phase to water phase at 60 C then slowly add the remaining ingredients while cooling. Add in the following: 0.5% Arrowroot powder, 0.15% tapioca starch, 1% grapefruit seed extract, 0.1% ascorbyl plamitate, 1% glucose, 0.05% Lactoperoxidase and 2% all natural fragrance. Mix additional 20 minutes or until homogenous.
  • Phase A (Water phase) Aloe/Zinc Pre-Mix.
  • Pure Aloe In a clean, sanitized and dry stainless steel vessel equipped with a homogenizer add, Pure Aloe. Pure aloe must be prepared as follows with water to neutralize the pH to 5.5 and 0.25% sodium bicarbonate in the aloe. Add 49.950 % aloe, 20% water, 11% zinc oxide Z-cote (no coating), 3.5% of 1.5% Eumulgin SG® or 2% Emulglade® PL68/50. Mix until homogeneous with 0.5% Aribinogalactan.
  • Phase B (Oil Phase) In a clean, sanitized and dry stainless steel vessel equipped with a homogenizer add 2.67% Raspberry Seed Oil, (or rice bran oil), 1% Hemp Seed Oil. Mix until homogeneous while heating to 80 deg.C. When Phase B is homogeneous and at 80 degrees Celsius add, 3% Stearic Acid. Mix until homogeneous. Continue mixing and cool Phase B to room temperature. Add 3% Ethyl Macadamiate, and Mix until homogeneous. When Phase B is homogeneous, add to Phase A and add 1.83% aloe. Mix with homogenizer for 20-30 minutes until homogeneous.
  • Phase A (Water phase) Heat to 60 deg.C; 14.25% water, 32.35% Aloe Juice w/carageenan and baking soda, 0.5% laracare A 200, 3% Eumulgin SG®, 1% Emulgade PL68/50® , 16% Zinc Oxide, 1% hydrolyzed wheat protein, 1% Crodesta F 160, 0.1% vitamin E, 0.1% ascorbic acid - vitamin C, 0% beta carotene. Homogenize water phase at 60 deg.C.
  • Phase B (Oil phase) Mix the following 2 ingredients together; 9% Rice Bran Oil and 0.2% Oryzinol.
  • EXAMPLE XXVI Phase A (Water phase) Heat to 60 deg.C; 14.75% water, 19.7% Whole leaf gel from Lilli of the Desert, 0.25% laracare A 200, 3% Eumulgin SG®, 1% Emulgade, 0% zinc oxide, 1% hydrolyzed wheat protein, 1% Crodesta F 160, 0.1% ascorbyl plamitate, 0.1% vitamin E, 0.1% ascorbic acid - vitamin C, 1% beta carotene, 0.1% orange wax, 1% beeswax. Homogenize water phase at 60 C.
  • Phase B (Oil phase) Mix the following 2 ingredients together; Ethyl Maccadamiate + zinc.
  • Phase A (Water phase) Heat to 60 deg.C; 14.75% water, 19.7% aloe juice w/baking soda, 0.25% laracare A 200, 3% Eumulgin SG®, 1% Emulgade, 0% zinc oxide, 1% hydrolyzed wheat protein, 1% Crodesta F 160, 0.1% ascorbyl plamitate, 0.1% vitamin E, 0.1% ascorbic acid - vitamin C, 1% beta carotene, 0.1% orange wax, 1% beeswax. Homogenize water phase at 80 deg.C.
  • Phase B (Oil phase) Mix the following 2 ingredients together; Ethyl Maccadamiate + zinc.
  • Phase A (Water phase) Heat to 80 deg.C; 27.25% water, 24.7% aloe juice w/baking soda, 0.25% laracare A 200, 3% Eumulgin SG®, 1% Emulgade PL 68/50, 7% Zinc Oxide. 1% hydrolyzed wheat protein, 1% Crodesta F 160, 0.1% ascorbyl plamitate, 0.1% Viramin E, 0.1% ascorbic acid - vitamin C, 1% beta carotene, 0.5% orange wax, 1% beeswax. Homogenize water phase at 80 deg.C.
  • Phase B (Oil phase) 0% coconut oil, 2.6% mixture of rice bran oil (2.5%) and oryzinol (0.1%), 16.5% raspberry seed oil, 0% hemp seed oil, 5% Ethyl Macadamiate, 1% stearic acid, 4% Zenigloss ®, 1% Avacado oil. Mix at 60 deg.C until homogenous. Add oil phase to water phase and increase temperature to 80 deg.C then slowly add the remaining ingredients while cooling. 0.25% Arrowroot powder, 0.1% tapioca starch, 0.5% grapefruit seed extract, 1% glucose, 0.05% Lactoperoxidase. Mix additional 20 minutes or until homogeneous.
  • EXAMPLE XXIX Phase A (Water phase) Heat to 80 deg.C; 19.75% water, 24.7% aloe juice w/baking soda, 0.25% laracare A 200, 3% Eumulgin SG®, 1% Emulgade, 0% Zinc Oxide, 1% hydrolyzed wheat protein, 1% Crodesta F 160, 0.1% ascorbyl plamitate, 0.1% Viramin E, 0.1% ascorbic acid - vitamin C, 1% beta carotene. Homogenize water phase at 80 deg.C.
  • Phase B (Oil phase) Mix the following 2 ingredients together; Ethyl Maccadamiate + zinc.
  • EXAMPLE XXX Phase A (Water phase) Heat to 80 deg.C; 27.25% water, 24.7% aloe juice w/baking soda, 0.25% laracare A 200, 3% Eumulgin SG®, 1% Emulgade PL68/50®, 7% Zinc Oxide, 1% hydrolyzed wheat protein, 1% Crodesta F 160, 0.1% ascorbyl plamitate, 0.1% Viramin E, 0.1% ascorbic acid - vitamin C, 1% beta carotene, 0.5% orange wax, 1% beeswax. Homogenize water phase at 80 deg.C.
  • Phase B (Oil phase) 0% coconut oil, 2.6% mixture of rice bran oil (2.5%) and oryzinol (0.1%), 16.5% raspberry seed oil, 0% hemp seed oil, 5% Ethyl Macadamiate, 1% stearic acid, 4% Zenigloss ®, 1% Avacado oil. Mix at 60 deg.C until homogenous. Add oil phase to water phase at 80 C then slowly add the remaining ingredients while cooling: 0.25% Arrowroot powder, 0.1% tapioca starch, 0.5% grapefruit seed extract, 1% glucose, 0.05%
  • Lactoperoxidase Mix additional 20 minutes or until homogeneous. Cease mixing.
  • Phase A (Water phase) Heat to 80 deg.C; 19.75% water, 24.7% aloe juice w/baking soda, 0.25% laracare A 200, 3% Eumulgin SG®, 1% Emulgade, 0% Zinc Oxide, 1% hydrolyzed wheat protein, 1% Crodesta F 160, 0.1% ascorbyl plamitate, 0.1% Vitamin E, 0.1% ascorbic acid - vitamin C, 1% beta carotene, 1% orange wax, 2% beeswax. Homogenize water phase at 80 deg.C.
  • Phase B (Oil phase) 0% coconut oil, 6% mixture of rice bran oil (5%) and oryzinol (1%), 21% raspberry seed oil, 0% hemp seed oil, 5% Ethyl Macadamiate, 1% stearic acid, 4% Zenigloss ®, 1% Avacado oil. Mix at 60 deg.C until homogenous. Add oil phase to water phase at 80 C then slowly add the remaining ingredients while cooling: 2% Arrowroot powder, 3% tapioca starch, 1% grapefruit seed extract, 1% glucose, 0.05% Lactoperoxidase. Mix additional 20 minutes or until homogeneous. Cease mixing.
  • Phase A (Water phase) Heat to 80 deg.C; 27.25% water, 24.7% aloe juice w/baking soda, 0.25% laracare A 200, 3% Eumulgin SG®, 1% Emulgade, 7% Zinc Oxide, 1% hydrolyzed wheat protein, 1% Crodesta F 160, 0.1% ascorbyl plamitate, 0.1% Viramin E, 0.1% ascorbic acid - vitamin C, 0% beta carotene, 0.5% orange wax, 1% beeswax. Homogenize water phase at 80 deg.C.
  • Phase B (Oil phase) 0% coconut oil, 2.6% mixture of rice bran oil (2.5%) and oryzinol (0.1%), 16.5% raspberry seed oil, 0% hemp seed oil, 5% Ethyl Macadamiate, 1% stearic acid, 4% Zenigloss ®, 1% Avacado oil. Mix at 60 deg.C until homogenous. Add oil phase to water phase at 80 C then slowly add the remaining ingredients while cooling: 0.25% Arrowroot powder, 0.1% tapioca starch, 0.5% grapefruit seed extract, 1% glucose, 0.05% Lactoperoxidase, 1.5% Emulgen, 1% Ethyl Macadamiate. Mix additional 20 minutes or until homogeneous. Cease mixing.
  • EXAMPLE XXXIII Phase A (Water phase) Heat to 80 deg.C; 42015% water, 16.75% aloe juice w/baking soda, 4% Eumulgin SG®,, 2% Emulgade PL68/50, 16% Zinc Oxide, 0% hydrolyzed wheat protein, 0% Crodesta F 160, 0 % ascorbyl plamitate, 0.1% Viramin E, 0.1% ascorbic acid - vitamin C, 0.1% beta carotene, 0.25% orange wax, 0.5% beeswax. Homogenize water phase at 80 degC.
  • Phase B (Oil phase) 1% Avacado oil, 1% mixture of rice bran oil (0.95%) and oryzinol (0.05%), 4% raspberry seed oil, 3% stearic acid, 6.5% ethyl maccadamiate. Mix at 80 deg.C until homogeneous. Add oil phase to water phase at 80 C then slowly add the remaining ingredients while cooling: 0.5% Laracare A200, 1% grapefruit seed extract, 1% glucose, 0.05% Lactoperoxidase. Mix additional 20 minutes or until homogeneous. Cease mixing.
  • essential oils or equivalent SPF boosting agents can be used including broccoli seed oil, pomegranate seed oil, and castor oil derivatives such as castor isostearate succinate as well as the previously documented silicone oils.
  • 0.1 g of orange wax, and 2.5 g of beeswax were mixed until all solids were dissolved, and the mixture was heated to 65° C.
  • 12.0 grams of micronized zinc oxide (Z-Cote ®), 4.8 grams of natural source tocopherol (D- alpha), and 4.8 grams of T-Cote ® are added to this second receptacle requiring good agitation and maintaining temperature until the micronized powders were properly wetted.
  • a high-energy mixer was used to disperse the ingredients.
  • the first receptacle (water phase) was then added to the second receptacle (oil phase) with high-speed mixing.
  • On a small scale (less than 200 grams), the addition of phases has been successfully reversed. Mixing continued until the composite was cooled.
  • 1.0 gram of Biovert® substrate (a product of Arch Chemicals and a composite of glucose, lactoperoxidase, and glucose oxidase) was then added, mixing thoroughly. 0.05 grams of Biovert® enzyme was added. The receptacle was mixed until smooth and homogenous.

Abstract

L'invention concerne une composition comprenant de l'eau purifiée à l'aide d'ozonation, d'ionisation ou de distillation ou n'importe quelle combinaison de celles-ci, où l'alcool peut être substitué pour, ou combiné avec de l'eau, au moins un émollient comprenant, mais sans s'y limiter, le chitosan et le gel de vrai aloès, individuellement ou dans n'importe quelle combinaison ; un composant huileux avec des agents de stimulation de spf comprenant, mais sans y être limités : le macadamiate d'éthyle, l'huile de silicone non-toxique et les huiles essentielles, le babeurre, des cires imprégnées d'un agent écran physique ou écran chimique inorganique et de particules micronisés organiques/inorganiques, la poudre de bois et l'argile de bentonite, la kératine, de façon soit individuelle soit en combinaison ; au moins un agent écran physique ou écran chimique inorganique comprenant l'un quelconque parmi un oxyde métallique, une microsphère en verre, de la silice et un composé de silice, et facultativement, des pigments d'oxyde métallique avec des particules qui sont micronisées, sous-micronisées, dimensionnées sous forme de nanoparticules, ou autrement individuellement ou dans n'importe quelle combinaison qui peut être homogénéisée soit dans une phase aqueuse, une phase eau-aloès, une phase huileuse ou n'importe quelle phase de ladite composition ; au moins un émulsifiant, ledit émulsifiant comprenant, mais sans y être limité, un phospholipide et/ou un liposome ou un gel de vrai aloès ou un ester d'huile de noix de coco individuellement ou dans n'importe quelle combinaison, pour émulsionner la phase aqueuse, eau-aloès ou huileuse en combinaison avec un homogénéisateur ; où n'importe lequel des composants est de préférence mélangé avec un homogénéisateur et où un agent épaississant approprié comprenant, mais sans y être limité, la gomme de xanthane, le carraghénane, soit individuellement, soit dans n'importe quelle combinaison, est ajouté selon les besoins.
EP08726964A 2007-03-07 2008-03-19 Compositions résistantes au rayonnement ultraviolet, biodégradables, cytoprotectrices, transparentes ou translucides, à spf élevé Withdrawn EP2134314A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90545307P 2007-03-07 2007-03-07
US91873107P 2007-03-19 2007-03-19
PCT/US2008/003580 WO2008136889A1 (fr) 2007-03-07 2008-03-19 Compositions résistantes au rayonnement ultraviolet, biodégradables, cytoprotectrices, transparentes ou translucides, à spf élevé

Publications (1)

Publication Number Publication Date
EP2134314A1 true EP2134314A1 (fr) 2009-12-23

Family

ID=39943804

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08726964A Withdrawn EP2134314A1 (fr) 2007-03-07 2008-03-19 Compositions résistantes au rayonnement ultraviolet, biodégradables, cytoprotectrices, transparentes ou translucides, à spf élevé

Country Status (2)

Country Link
EP (1) EP2134314A1 (fr)
WO (1) WO2008136889A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2184052B1 (fr) * 2008-11-11 2017-09-20 Kao Germany GmbH Composition pour cheveux
FR2971707B1 (fr) * 2011-02-18 2013-02-15 Oreal Composition cosmetique aqueuse contenant des particules de materiau composite et du gamma-oryzanol
FR2975286A1 (fr) * 2011-05-20 2012-11-23 Durance Compositions cosmetiques et procedex de soins specifiques des peaux matures, a base de grenade
US20140322286A1 (en) * 2011-11-17 2014-10-30 Sakai Chemical Industry Co., Ltd. Surface treated zinc oxide powder, antibacterial agent, and antibacterial composition
PL422959A1 (pl) * 2017-09-25 2019-04-08 Upadhyay Shakti Metoda aktywacji kompozycji kosmetycznej i kompozycja kosmetyczna
CN112754947B (zh) * 2021-01-12 2022-12-16 上海百雀羚生物科技有限公司 一种高效中和无机防晒剂产生自由基的防护体系及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0163942B1 (ko) * 1995-12-23 1998-12-01 이능희 색조 화장료용 복합안료의 제조방법
US5824659A (en) * 1996-09-04 1998-10-20 Board Of Regents, The University Of Texas System Cytoprotective oligosaccharide from Aloe preventing damage to the skin immune system by UV radiation
US5945090A (en) * 1997-09-11 1999-08-31 Randall Products International Sunscreen preparation
US6866841B2 (en) * 2001-08-09 2005-03-15 Epatentmanager.Com Non-endocrine disrupting cytoprotective UV radiation resistant substance

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2008136889A1 *

Also Published As

Publication number Publication date
WO2008136889A1 (fr) 2008-11-13

Similar Documents

Publication Publication Date Title
US9095522B2 (en) High SPF transparent or translucent, cytoprotective, biodegradable, UV radiation resistant compositions
US20080219938A1 (en) SPF compositions
JP5222288B2 (ja) アンチエイジング作用を有するスキンケア複合体を含む化粧製剤
US20080219939A1 (en) Sunblock formulations
US20150110724A1 (en) High SPF Transparent or Translucent Naturally Derived, Cytoprotective, UV Radiation Resistant Compositions
US20050196361A1 (en) Non endocrine disrupting cytoprotective UV radiation resistant composition
US9782610B2 (en) Nontoxic, non-endocrine disrupting, cytoprotective, UV-radiation resistant sunblock compositions
EP1804923B1 (fr) Composition cosmetique regulatrice d'humidite
JP2007533690A (ja) 日焼け用製品セットおよび日焼け用製品で肌を手入れする美容方法
US11096886B2 (en) Oat lipid extract
US20020197292A1 (en) Sunscreen formulations
EP2134314A1 (fr) Compositions résistantes au rayonnement ultraviolet, biodégradables, cytoprotectrices, transparentes ou translucides, à spf élevé
EP2323969B1 (fr) UTILISATION D´ESTERS DÉRIVÉS DE SOURCES NATURELLES AYANT UNE VISCOSITÉ RÉDUITE ET UNE VITESSE DE PROPAGATION ACCRUE et PRÈPARATION DE COMPOSITIONS NATURELLES DE SOINS PERSONNELS LES COMPRENANT
KR102051058B1 (ko) 아스코빅 애씨드 분산물 및 이를 함유하는 화장료 조성물
US8557264B2 (en) Glycerine based jelly compositions
US20020012648A1 (en) High phospholipid-containing dermatological compositions
KR20190142655A (ko) 7-데하이드로콜레스테롤, 콜레스테롤 및 스테아린산이 히알루론산-세라마이드 엔피 복합체의 내상에 봉입된 나노에멀젼을 함유하는 화장료 조성물 및 그의 제조방법
CA3095131A1 (fr) Procede pour produire une formulation de depart pour une preparation dermatologique de protection contre la lumiere et pour produire une preparation dermatologique de protection c ontre la lumiere
KR20110071519A (ko) 삼중 안정화된 비타민 ｃ함유 미백 화장료 조성물
EP1855635A1 (fr) Preparation cosmetique pour prolonger le bronzage
US9913787B2 (en) Glycerine based jelly compositions
RU2236842C1 (ru) Крем для век "диамант"
JP2016188190A (ja) マスキング組成物

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20091006

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20151001